Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 286-297 , June 2010

Aetiology of childhood leukaemia

  • Tim Eden

      Affiliations

    • Corresponding Author InformationAddress: c/o Academic Unit of Paediatric and Adolescent Oncology, Teenage Cancer Trust Young Oncology Unit, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, England, UK. Tel.: +44 161 446 3094; fax: +44 161 446 3092.

References 

  1. Kersey JH. Fifty years of studies of the biology and therapy of childhood leukemia. Blood. 1997;90(11):4243–4251
  2. Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. New Engl J Med. 2004;350(15):1535–1548
  3. Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature. 1993;363(6427):358–360
  4. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997;94(25):13950–13954
  5. Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet. 1999;354(9189):1499–1503
  6. Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood. 2002;99(10):3801–3805
  7. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102(7):2321–2333
  8. Mori H, Colman SM, Xiao Z, Ford AM, Healy LE, Donaldson C, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA. 2002;99(12):8242–8247
  9. Greaves M. Childhood leukaemia. Clin Rev BMJ. 2002;324(7332):283–287
  10. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193–203
  11. Parkin DM, Kramarova GJ, Draper G, et al., editors. International incidence of childhood cancer, vol. II. Lyon: IARC Scientific Publications No. 144; 1998.
  12. Little J. Epidemiology of childhood cancer. Lyon; IARC Scientific Publications No. 149; 1999.
  13. McNally RJ, Eden TO. An infectious aetiology for childhood acute leukaemia: a review of the evidence. Brit J Haematol. 2004;127(3):243–263
  14. Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3(9):639–649
  15. Alexander FE, Williams J, Maisonneuve P, Boyle P. Methods for investigating localized clustering of disease. The simulated data-sets. IARC Scientific Publications No. 135; 1996. p. 21–7.
  16. Westerbeek RM, Blair V, Eden OB, Kelsey AM, Stevens RF, Will AM, et al. Seasonal variations in the onset of childhood leukaemia and lymphoma. Brit J Cancer. 1998;78(1):119–124
  17. Kinlen L. Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet. 1988;2(8624):1323–1327
  18. Kinlen LJ, Clarke K, Hudson C. Evidence from population mixing in Brit New Towns 1946–85 of an infective basis for childhood leukaemia. Lancet. 1990;336(8715):577–582
  19. Kinlen LJ, Johns SM. Wartime evacuation of children and mortality from childhood leukaemia in England and Wales in 1945–9. BMJ. 1994;309(6963):1197–1202
  20. Kinlen LJ, Hudson C. Childhood leukaemia and poliomyelitis in relation to military encampments in England and Wales in the period of national military service, 1950–63. BMJ. 1991;303(6814):1357–1362
  21. Kinlen LJ, Balkwill A. Infective cause of childhood leukaemia and wartime population mixing in Orkney and Shetland, UK. Lancet. 2001;357(9259):858
  22. Kinlen L, Doll R. Population mixing and childhood leukaemia: Fallon and other US clusters. Brit J Cancer. 2004;91(1):1–3
  23. Stiller CA, Boyle PJ. Effect of population mixing and socioeconomic status in England and Wales, 1979–85, on lymphoblastic leukaemia in children. BMJ. 1996;313(7068):1297–1300
  24. Stiller CA, Kroll ME, Boyle PJ, Feng Z. Population mixing, socioeconomic status and incidence of childhood acute lymphoblastic leukaemia in England and Wales: analysis by census ward. Brit J Cancer. 2008;98(5):1006–1011
  25. The United Kingdom Childhood Cancer Study: objectives, materials and methods. UK Childhood Cancer Study Investigators. Brit J Cancer 2000;82(5):1073–102.
  26. Law GR, Parslow RC, Roman E. United Kingdom Childhood Cancer Study Investigators. Childhood cancer and population mixing. Am J Epidemiol. 2003;158(4):328–336
  27. Parslow RC, Law GR, Feltbower R, Kinsey SE, McKinney PA. Population mixing, childhood leukaemia, CNS tumours and other childhood cancers in Yorkshire. Eur J Cancer. 2002;38(15):2033–2040
  28. Adelman AS, Groves FD, O’Rourke K, Sinha D, Hulsey TC, Lawson AB, et al. Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study. Brit J Cancer. 2007;97(1):140–144
  29. Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia. 1988;2(2):120–125
  30. Taylor GM, Birch JM. The hereditary basis of human leukaemia. In:  Henderson ES,  Lister TA,  Greaves MF editor. Leukaemia. 6th ed.. Philadelphia: WB Saunders; 1996;p. 210–245
  31. Hasle H. Pattern of malignant disorders in individuals with Down’s syndrome. Lancet Oncol. 2001;2(7):429–436
  32. Senator H. Zur kenntniss der leukamie und pseudoleukamie im kindesatter. Berl Kilnis Wochenschr. 1882;35:533–536
  33. Maia AT, Ford AM, Jalali GR, Harrison CJ, Taylor GM, Eden OB, et al. Molecular tracking of leukemogenesis in a triplet pregnancy. Blood. 2001;98(2):478–482
  34. Lamb J, Crawford ED, Peck D. The connectivity map: using gene expression signatures to connect small molecules, genes and disease. Science. 2006;313:1929–1935
  35. Greaves MF. Aetiology of acute leukaemia. Lancet. 1997;349(9048):344–349
  36. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst. 1994;86(22):1678–1680
  37. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential DNA topoisomerase II inhibitors and infant leukemia (United States): a report from the Children’s Cancer Group. Cancer Causes Control. 1996;7(6):581–590
  38. Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, et al. Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA. 1998;95(22):13176–13181
  39. Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greaves MF United Kingdom Childhood Cancer Study Investigators. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. Cancer Res. 1999;59(16):4095–4099
  40. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci USA. 2000;97(9):4790–4795
  41. Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, et al. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood. 2002;100(13):4590–4593
  42. Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, et al. Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Brit J Cancer. 1997;76(7):852–854
  43. Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 1996;56(21):4862–4864
  44. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA. 1999;96(22):12810–12815
  45. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE, Greaves MF United Kingdom Childhood Cancer Study Investigators. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA. 2001;98(7):4004–4009
  46. Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention?. Gut. 2006;55:1387–1389
  47. Mason JB. Folate, cancer risk and the Greek god, Proteus: a tale of two chameleons. Nutr Rev. 2009;67:206–212
  48. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Brit J Radiol. 1997;70:130–139
  49. United Kingdom Childhood Cancer Study Investigators: the UK.CCS of exposure to sources of ionising radiation: 1: radon gas. Brit J Cancer 2002;86(11):1721–6.
  50. United Kingdom Childhood Cancer Study Investigators: the United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 2: gamma radiation. Brit J Cancer 2002;86(11):1727–31.
  51. Axelson O, Fredrikson M, Akerblom G, Hardell L. Leukemia in childhood and adolescence and exposure to ionizing radiation in homes built from uranium-containing alum shale concrete. Epidemiology. 2002;13(2):146–150
  52. Kaletsch U, Kaatsch P, Meinert R, Schuz J, Czarwinski R, Michaelis J. Childhood cancer and residential radon exposure – results of a population-based case-control study in Lower Saxony (Germany). Radiat Environ Biophys. 1999;38(3):211–215
  53. Meinert R, Kaletsch U, Kaatsch P, Schuz J, Michaelis J. Associations between childhood cancer and ionizing radiation: results of a population-based case-control study in Germany. Cancer Epidemiol Biomark Prev. 1999;8(9):793–799
  54. Stewart A, Webb J, Hewitt D. A survey of childhood malignancies. Brit Med J. 1958;1(5086):1495–1508
  55. Infante-Rivard C. Diagnostic X-rays, DNA repair genes and childhood acute lymphoblastic leukemia. Health Phys. 2003;85(1):60–64
  56. Hatch EE, Linet MS, Kleinerman RA, Tarone RE, Severson RK, Hartsock CT, et al. Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology. 1998;9(3):234–245
  57. UK Childhood Cancer Study Investigators. Exposure to power-frequency magnetic fields and the risk of childhood cancer. Lancet 1999;354(9194):1925–31.
  58. Ahlbom A, Day N, Feychting M, Roman E, Skinner J, Dockerty J, et al. A pooled analysis of magnetic fields and childhood leukaemia. Brit J Cancer. 2000;83(5):692–698
  59. Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. A pooled analysis of magnetic fields, wire codes, and childhood leukemia. Childhood Leukemia-EMF Study Group. Epidemiology. 2000;11(6):624–634
  60. Kheifets L, Oksuzyan S. Exposure assessment and other challenges in non-ionizing radiation studies of childhood leukaemia. Radiat Protect Dosim. 2008;132(2):139–147
  61. Feychting M, Ahlbom A. Magnetic fields and cancer in children residing near Swedish high-voltage power lines. Am J Epidemiol. 1993;138(7):467–481
  62. Skinner J, Mee TJ, Blackwell RP, Maslanyj MP, Simpson J, Allen SG, et al. Exposure to power frequency electric fields and the risk of childhood cancer in the UK. Brit J Cancer. 2002;87(11):1257–1266
  63. Draper G, Vincent T, Kroll ME, Swanson J. Childhood cancer in relation to distance from high voltage power lines in England and Wales: a case-control study. BMJ. 2005;330(7503):1290
  64. Dickinson HO. The causes of childhood leukaemia. BMJ. 2005;330(7503):1279–1280
  65. Twisselmann B. Summary of responses to Draper et al. paper. BMJ 2005;331–636.
  66. Henshaw DL, Ross AN, Fews AP, Preece AW. Enhanced deposition of radon daughter nuclei in the vicinity of power frequency electromagnetic fields. Int J Radiat Biol. 1996;69(1):25–38
  67. Fews AP, Henshaw DL, Wilding RJ, Keitch PA. Corona ions from powerlines and increased exposure to pollutant aerosols. Int J Radiat Biol. 1999;75(12):1523–1531
  68. Meinert R, Schuz J, Kaletsch U, Kaatsch P, Michaelis J. Leukemia and non-Hodgkin’s lymphoma in childhood and exposure to pesticides: results of a registry based case-control study in Germany. Am J Epidemiol. 2000;151(7):639–646[discussion 47–50]
  69. Shu XO, Stewart P, Wen WQ, Han D, Potter JD, Buckley JD, et al. Parental occupational exposure to hydrocarbons and risk of acute lymphocytic leukemia in offspring. Cancer Epidemiol Biomark Prev. 1999;8(9):783–791
  70. Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J. Risk of childhood leukemia and parental self-reported occupational exposure to chemicals, dusts, and fumes: results from pooled analyses of German population-based case-control studies. Cancer Epidemiol Biomark Prev. 2000;9(8):835–838
  71. Savitz DA, Andrews KW. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Indust Med. 1997;31(3):287–295
  72. Feychting M, Svensson D, Ahlbom A. Exposure to motor vehicle exhaust and childhood cancer. Scand J Work Environ Health. 1998;24(1):8–11
  73. Crosignani P, Tittarelli A, Borgini A, Codazzi T, Rovelli A, Porro E, et al. Childhood leukemia and road traffic: a population-based case-control study. Int J Cancer. 2004;108(4):596–599
  74. Infante-Rivard C, Olson E, Jacques L, Ayotte P. Drinking water contaminants and childhood leukemia. Epidemiology. 2001;12(1):13–19
  75. Costas K, Knorr RS, Condon SK. A case-control study of childhood leukemia in Woburn, Massachusetts: the relationship between leukemia incidence and exposure to public drinking water. Sci Total Environ. 2002;300(1–3):23–25
  76. Severson RK, Buckley JD, Woods WG, Benjamin D, Robison LL. Cigarette smoking and alcohol consumption by parents of children with acute myeloid leukemia: an analysis within morphological subgroups – a report from the Childrens Cancer Group. Cancer Epidemiol Biomark Prev. 1993;2(5):433–439
  77. Shu XO, Ross JA, Pendergrass TW, Reaman GH, Lampkin B, Robison LL. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study. J Natl Cancer Inst. 1996;88(1):24–31
  78. Sorahan T, Prior P, Lancashire RJ, Faux SP, Hulten MA, Peck IM, et al. Childhood cancer and parental use of tobacco: deaths from 1971 to 1976. Brit J Cancer. 1997;76(11):1525–1531
  79. Thornton AJ, Lee PN. Parental smoking and risk of childhood cancer: a review of the evidence. Indoor Built Environ. 1998;7:65–86
  80. Pang D, McNally R, Birch JM. Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study. Brit J Cancer. 2003;88(3):373–381
  81. Infante-Rivard C, Krajinovic M, Labuda D, Sinnett D. Childhood acute lymphoblastic leukemia associated with parental alcohol consumption and polymorphisms of carcinogen-metabolizing genes. Epidemiology. 2002;13(3):277–281
  82. Ford AM, Pombo-de-Oliveira MS, McCarthy KP, MacLean JM, Carrico KC, Vincent RF, et al. Monoclonal origin of concordant T-cell malignancy in identical twins. Blood. 1997;89(1):281–285
  83. Hjalgrim LL, Madsen HO, Melbye M, Jorgensen P, Christiansen M, Andersen MT, et al. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Brit J Cancer. 2002;87(9):994–999
  84. Roman E, Simpson J, Ansell P, Lightfoot T, Mitchell C, Eden TO. UK Childhood Cancer Study Investigators. Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS. Eur J Cancer. 2005;41(5):749–759
  85. McKinney PA, Juszczak E, Findlay E, Smith K, Thomson CS. Pre- and perinatal risk factors for childhood leukaemia and other malignancies: a Scottish case control study. Brit J Cancer. 1999;80(11):1844–1851
  86. Reynolds P, Von Behren J, Elkin EP. Birth characteristics and leukemia in young children. Am J Epidemiol. 2002;155(7):603–613
  87. Cnattingius S, Zack MM, Ekbom A, Gunnarskog J, Kreuger A, Linet M, et al. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst. 1995;87(12):908–914
  88. Shu XO, Gao YT, Brinton LA, Linet MS, Tu JT, Zheng W, et al. A population-based case-control study of childhood leukemia in Shanghai. Cancer. 1988;62(3):635–644
  89. Ma X, Buffler PA, Selvin S, Matthay KK, Wiencke JK, Wiemels JL, et al. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Brit J Cancer. 2002;86(9):1419–1424
  90. Petridou E, Trichopoulos D, Kalapothaki V, Pourtsidis A, Kogevinas M, Kalmanti M, et al. The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Brit J Cancer. 1997;76(9):1241–1247
  91. Thompson JR, Gerald PF, Willoughby ML, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet. 2001;358(9297):1935–1940
  92. Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S. Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer Causes Control. 2004;15(6):559–570
  93. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K and prttudine given during labour. Brit Med J. 1992;305:341–346
  94. Parker L, Cole M, Craft AW, Hey EN. Neonatal vitamin K administration and childhood cancer in the North of England: retrospective case-control study. BMJ. 1998;316(7126):189–193
  95. Passmore SJ, Draper G, Brownbill P, Kroll M. Case-control studies of relation between childhood cancer and neonatal vitamin K administration. BMJ. 1998;316(7126):178–184
  96. Fear NT, Roman E, Ansell P, Simpson J, Day N, Eden OB. Vitamin K and childhood cancer: a report from the United Kingdom Childhood Cancer Study. Brit J Cancer. 2003;89(7):1228–1231
  97. Roman E, Fear NT, Ansell P, Bull D, Draper G, McKinney P, et al. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Brit J Cancer. 2002;86(1):63–69
  98. Ansell P, Roman E, Fear NT, Simpson J, Day N, Eden T. Vitamin K update: survey of paediatricians in the UK. Brit J Midwifery. 2004;12(1):38–41
  99. Poynton FJ, Thursfield H, Paterson D. The severe ‘blood diseases’ of childhood:a series of observations from the Hospital of Sick Children, Great Ormand Street. Brit J Child Dis. 1992;XIX:128–144
  100. Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax. 2000;55(Suppl 1):S2–S10
  101. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science. 2002;296(5567):490–494
  102. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001;1(1):69–75
  103. Kolb H, Elliott RB. Increasing incidence of IDDM a consequence of improved hygiene?. Diabetologia. 1994;37(7):729
  104. Alvord EC, Jahnke U, Fischer EH, Kies MW, Driscoll BF, Compston DA. The multiple causes of multiple sclerosis: the importance of age of infections in childhood. J Child Neurol. 1987;2(4):313–321
  105. MacKenzie J, Perry J, Ford AM, Jarrett RF, Greaves M. JC and BK virus sequences are not detectable in leukaemic samples from children with common acute lymphoblastic leukaemia. Brit J Cancer. 1999;81(5):898–899
  106. Smith MA, Strickler HD, Granovsky M, Reaman G, Linet M, Daniel R, et al. Investigation of leukemia cells from children with common acute lymphoblastic leukemia for genomic sequences of the primate polyomaviruses JC virus, BK virus, and simian virus 40. Med Pediatr Oncol. 1999;33(5):441–443
  107. Priftakis P, Dalianis T, Carstensen J, Samuelsson U, Lewensohn-Fuchs I, Bogdanovic G, et al. Human polyomavirus DNA is not detected in Guthrie cards (dried blood spots) from children who developed acute lymphoblastic leukemia. Med Pediatr Oncol. 2003;40(4):219–223
  108. Isa A, Priftakis P, Broliden K, Gustafsson B. Human parvovirus B19 DNA is not detected in Guthrie cards from children who have developed acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004;42(4):357–360
  109. Bogdanovic G, Jernberg AG, Priftakis P, Grillner L, Gustafsson B. Human herpes virus 6 or Epstein-Barr virus were not detected in Guthrie cards from children who later developed leukaemia. Brit J Cancer. 2004;91(5):913–915
  110. MacKenzie J, Gallagher A, Clayton RA, Perry J, Eden OB, Ford AM, et al. Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia. 2001;15(3):415–421
  111. Bender AP, Robison LL, Kashmiri SV, McClain KL, Woods WG, Smithson WA, et al. No involvement of bovine leukemia virus in childhood acute lymphoblastic leukemia and non-Hodgkin’s lymphoma. Cancer Res. 1988;48(10):2919–2922
  112. Shiramizu B, Yu Q, Hu N, Yanagihara R, Nerurkar VR. Investigation of TT virus in the etiology of pediatric acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2002;19(8):543–551
  113. Kerr JR, Barah F, Cunniffe VS, Smith J, Vallely PJ, Will AM, et al. Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia. J Clin Pathol. 2003;56(11):873–875
  114. Lehtinen M, Koskela P, Ogmundsdottir HM, Bloigu A, Dillner J, Gudnadottir M, et al. Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. Am J Epidemiol. 2003;158(3):207–213
  115. Naumburg E, Bellocco R, Cnattingius S, Jonzon A, Ekbom A. Perinatal exposure to infection and risk of childhood leukemia. Med Pediatr Oncol. 2002;38(6):391–397
  116. Infante-Rivard C, Fortier I, Olson E. Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia. Brit J Cancer. 2000;83(11):1559–1564
  117. Roman E, Ansell P, Bull D. Leukaemia and non-Hodgkin’s lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease?. Brit J Cancer. 1997;76(3):406–415
  118. Buckley JD, Buckley CM, Ruccione K, Sather HN, Waskerwitz MJ, Woods WG, et al. Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group. Leukemia 1994;8(5):856–64.
  119. Docherty JD, Skegg DC, Elwood JM, Herbison GP, Becroft DM, Lewis ME. Infections, vaccinations, and the risk of childhood leukaemia. Brit J Cancer. 1999;80(9):1483–1489
  120. Smith MA, Simon R, Strickler HD, McQuillan G, Ries LA, Linet MS. Evidence that childhood acute lymphoblastic leukemia is associated with an infectious agent linked to hygiene conditions. Cancer Causes Control. 1998;9(3):285–298
  121. Groves FD, Gridley G, Wacholder S, Shu XO, Robison LL, Neglia JP, et al. Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA. Brit J Cancer. 1999;81(1):175–178
  122. Schuz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J. Association of childhood leukaemia with factors related to the immune system. Brit J Cancer. 1999;80(3–4):585–590
  123. Nishi M, Miyake H. A case-control study of non-T cell acute lymphoblastic leukaemia of children in Hokkaido, Japan. J Epidemiol Community Health. 1989;43(4):352–355
  124. McKinney PA, Cartwright RA, Saiu JM, Mann JR, Stiller CA, Draper GJ, et al. The inter-regional epidemiological study of childhood cancer (IRESCC): a case control study of aetiological factors in leukaemia and lymphoma. Arch Dis Childhood. 1987;62(3):279–287
  125. UK Case Control Study Investigators. Breastfeeding and childhood cancer. Brit J Cancer 2001;85(11):1685–94.
  126. Perrillat F, Clavel J, Jaussent I, Baruchel A, Leverger G, Nelken B, et al. Breast-feeding, fetal loss and childhood acute leukaemia. Eur J Pediatr. 2002;161(4):235–237
  127. Urayama KY, Ma X, Buffler PA. Exposure to infections through day-care attendance and risk of childhood leukaemia. Radiat Protect Dosim. 2008;132(2):259–266
  128. Gilham C, Peto J, Simpson J, Roman E, Eden TO, Greaves MF, et al. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ. 2005;330(7503):1294
  129. Ma X, Buffler PA, Wiemels JL, Selvin S, Metayer C, Loh M, et al. Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomark Prev. 2005;14(8):1928–1934
  130. Kramer U, Heinrich J, Wjst M, Wichmann HE. Age of entry to day nursery and allergy in later childhood. Lancet. 1999;353(9151):450–454
  131. McKinney PA, Okasha M, Parslow RC, Law GR, Gurney KA, Williams R, et al. Early social mixing and childhood type 1 diabetes mellitus: a case-control study in Yorkshire, UK. Diabet Med. 2000;17(3):236–242
  132. Hughes AM, Lightfoot T, Simpson J, Ansell P, McKinney PA, Kinsey SE, et al. Allergy and risk of childhood leukaemia: results from the UKCCS. Int J Cancer. 2007;121(4):819–824
  133. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259–1260
  134. Von Hertzen LC, Haahtela T. Asthma and atopy – the price of affluence?. Allergy. 2004;59(2):124–137
  135. Taylor GM, Dearden S, Payne N, Ayres M, Gokhale DA, Birch JM, et al. Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Brit J Cancer. 1998;78(5):561–565
  136. Taylor GM, Dearden S, Ravetto P, Ayres M, Watson P, Hussain A, et al. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1∗0201. Human Mol Genet. 2002;11(14):1585–1597
  137. Dorak MT, Lawson T, Machulla HK, Darke C, Mills KI, Burnett AK. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood. 1999;94(2):694–700
  138. Heegaard ED, Madsen HO, Schmiegelow K. Transient pancytopenia preceding acute lymphoblastic leukaemia (pre-ALL) precipitated by parvovirus B19. Brit J Haematol. 2001;114(4):810–813
  139. Ishikawa K, Seriu T, Watanabe A, Hayasaka K, Takeda O, Sato T, et al. Detection of neoplastic clone in the hypoplastic and recovery phases preceding acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain gene. J Pediatr Hematol Oncol. 1995;17(3):270–275
  140. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7(3):211–217
  141. Ford AM, Cardus P, Greaves MF. Modelling molecular consequences of leukaemia initiation by TEL-AML1 fusion. Blood. 2004;104:566

PII: S0305-7372(10)00024-1

doi: 10.1016/j.ctrv.2010.02.004

Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 286-297 , June 2010

Article Tools

* Image Usage & Resolution